These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10571617)

  • 1. The pharmacological treatment of urinary incontinence.
    Andersson KE; Appell R; Cardozo LD; Chapple C; Drutz HP; Finkbeiner AE; Haab F; Vela Navarrete R
    BJU Int; 1999 Dec; 84(9):923-47. PubMed ID: 10571617
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of overactive bladder].
    Hunskår S
    Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2029-30. PubMed ID: 16100546
    [No Abstract]   [Full Text] [Related]  

  • 3. Solifenacin and darifenacin for overactive bladder.
    Obstet Gynecol; 2005 Aug; 106(2):401-2. PubMed ID: 16055596
    [No Abstract]   [Full Text] [Related]  

  • 4. Review. Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine.
    Kobelt G; Kirchberger I; Malone-Lee J
    BJU Int; 1999 Apr; 83(6):583-90. PubMed ID: 10233562
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-surgical management of urinary incontinence in children.
    Duel B
    ScientificWorldJournal; 2009 Nov; 9():1306-7. PubMed ID: 19936567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of overactive bladder].
    Schiøtz H
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2525-6; author reply 2526. PubMed ID: 16186882
    [No Abstract]   [Full Text] [Related]  

  • 7. An update on the pharmacotherapy for lower urinary tract dysfunction.
    Abraham N; Goldman HB
    Expert Opin Pharmacother; 2015 Jan; 16(1):79-93. PubMed ID: 25351368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of female urinary incontinence].
    Hampel C; Gillitzer R; Pahernik S; Melchior SW; Thüroff JW
    Urologe A; 2005 Mar; 44(3):244-55. PubMed ID: 15711814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication update.
    Slagle M
    South Med J; 2002 Feb; 95(2):188-91. PubMed ID: 11846243
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.
    Ruggieri MR; Braverman AS; Pontari MA
    J Urol; 2005 Nov; 174(5):1743-8. PubMed ID: 16217275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of urinary incontinence.
    Cipullo LM; Zullo F; Cosimato C; Di Spiezio Sardo A; Troisi J; Guida M
    Female Pelvic Med Reconstr Surg; 2014; 20(4):185-202. PubMed ID: 24978084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bladder storage and voiding dysfunctions : Side effects of drug therapy].
    Wolfesberger J; Falkensammer CE; Madersbacher S
    Urologe A; 2017 Apr; 56(4):456-464. PubMed ID: 28233038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity.
    Landis JR; Kaplan S; Swift S; Versi E
    J Urol; 2004 Feb; 171(2 Pt 1):752-6. PubMed ID: 14713803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptor antagonists in the treatment of overactive bladder.
    Chapple CR
    Urology; 2000 May; 55(5A Suppl):33-46; discussion 50. PubMed ID: 10767450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactive bladder: an update.
    Hashim H; Abrams P
    Curr Opin Urol; 2007 Jul; 17(4):231-6. PubMed ID: 17558264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in muscarinic receptors of the aging bladder].
    Andersson KE; Schröder A
    Urologe A; 2004 May; 43(5):552-6. PubMed ID: 15098089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder.
    Swift S; Garely A; Dimpfl T; Payne C;
    Int Urogynecol J Pelvic Floor Dysfunct; 2003 Feb; 14(1):50-4; discussion 54-5. PubMed ID: 12601517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies.
    Hegde SS; Mammen M; Jasper JR
    Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolterodine use for symptoms of overactive bladder.
    Ruscin JM; Morgenstern NE
    Ann Pharmacother; 1999 Oct; 33(10):1073-82. PubMed ID: 10534221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic management of urinary incontinence.
    Thomas DR
    Clin Geriatr Med; 2004 Aug; 20(3):511-23, vii-viii. PubMed ID: 15341812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.